Medtronic, Inc. PT Maintained at Mizuho Securities
By Davit Kirakosyan KeyBanc downgraded PayPal (NASDAQ:PYPL) to Sector Weight from Overweight amid “fundamental uncertainty". According to the firm, branded share gains could...
By Sam Boughedda Mizuho analysts said in a note on medtech and diagnostics stocks on Thursday that the firm's top longs include Alcon (NYSE:ALC), Cooper Companies (NYSE:COO) and...
-- Medtronic plc (NYSE:MDT) recently became aware that TRC Capital Investment Corporation (TRC) has made an unsolicited mini-tender offer to purchase up to 1,500,000 Medtronic...
Medtronic (NYSE: MDT) stock is currently hovering near an eight-year low due to the stock declining by about 23.5% over the past year and 42% from its 2021 high. Does this...
A look at 12 “forever” stocks coming from various industries, including technology, healthcare, and consumer goods, with solid track records of growth and stability.
Medtronic plc is a global healthcare technology company. The Company develops, manufactures, and markets its medical devices and technologies to hospitals, physicians, clinicians, and patients. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes. Cardiovascular products include pacemakers, insertable cardiac monitors, and cardiac resynchronization therapy devices. Medical Surgical products include patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. Neuroscience products include various spinal implants, bone graft substitutes, biologic products, image-guided surgery and intra-operative imaging systems. Diabetes products include insulin pumps, continuous glucose monitoring (CGM) systems, consumables, and smart insulin pen systems. It also provides PROPEL and SINUVA. The Company is focused on cardiac ablation portfolio.
|Average||93.60 (+13.05% Upside)|
|No. of Analysts||24|